---
$id: https://graph.org.ai/products/commodity/51172140
$type: Product
source: UNSPSC
code: "51172140"
title: "Mofloverine"
class: "51172100"
classTitle: "Antispasmodics"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mofloverine

**UNSPSC Code**: 51172140
**Class**: [Antispasmodics](Antispasmodics.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antispasmotic agent with the molecular formula C16H23NO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L1G37N4EBS, chemically known as 2,4,6-trimethoxybenzoic acid 2-morpholinoethyl ester but generally known as mofloverine, which bears US NIH Compound Identifier 172304. European Medicines Agency schedules Mofloverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09036MIG. The term MOFLOVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). MOFLOVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mofloverine under HS 29349990 and SITC 51579. As of Q4 2014, MOFLOVERINE remains the US FDA Preferred Term for this commodity. Mofloverine bears US NLM identifiers UMLS ID C1881880 and NCI Concept Code C66177. SMILES: O1CCN(CC1)CCOC(=O)C1C(OC)CC(OC)CC1OC.

